The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells

Breast Cancer Research and Treatment

Volumn 124, Issue 1, 2010, Pages 89-99

  Masri, Selma ^a   Liu, Zheng ^a   Phung, Sheryl ^a   Wang, Emily ^a   Yuan, Yate Ching ^a   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase inhibitor resistance; Estrogen; MicroRNA; MiR 128a; TGF

Indexed keywords

LETROZOLE; MICRORNA; MICRORNA 128A; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; UPREGULATION;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS; AROMATASE; AROMATASE INHIBITORS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NITRILES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TESTOSTERONE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TRIAZOLES;

EID: 77957709001     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0716-3     Document Type: Article

References (44)

1. JD Yager JG Liehr 1996 Molecular mechanisms of estrogen carcinogenesis Annu Rev Pharmacol Toxicol 36 203 232 1:CAS:528:DyaK28Xis1ertbw%3D 10.1146/annurev.pa.36.040196.001223 8725388
2. W Yue RJ Santen JP Wang, et al. 2003 Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis J Steroid Biochem Mol Biol 86 3-5 477 486 1:CAS:528:DC%2BD3sXptVemsbw%3D 10.1016/S0960-0760(03)00377-7 14623547
3. SJ Santner S Chen D Zhou Z Korsunsky J Martel RJ Santen 1993 Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture J Steroid Biochem Mol Biol 44 4-6 611 616 1:CAS:528: DyaK3sXktVWhsbo%3D 10.1016/0960-0760(93)90267-Z 8476772
4. W Yue JP Wang CJ Hamilton LM Demers RJ Santen 1998 In situ aromatization enhances breast tumor estradiol levels and cellular proliferation Cancer Res 58 5 927 932 1:CAS:528:DyaK1cXhsFersrk%3D 9500452
5. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351(9114):1451-1467
6. RC Coombes E Hall LJ Gibson, et al. 2004 A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 350 11 1081 1092 1:CAS:528: DC%2BD2cXitV2qtbc%3D 10.1056/NEJMoa040331 15014181
7. PE Goss JN Ingle S Martino, et al. 2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 19 1793 1802 1:CAS:528:DC%2BD3sXosl2gtbc%3D 10.1056/NEJMoa032312 14551341
8. A Howell J Cuzick M Baum, et al. 2005 Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 9453 60 62 1:STN:280: DC%2BD2M%2FhsVartA%3D%3D 10.1016/S0140-6736(04)17666-6 15639680
9. DJ Britton IR Hutcheson JM Knowlden, et al. 2006 Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth Breast Cancer Res Treat 96 2 131 146 1:CAS:528:DC%2BD28XivVentrw%3D 10.1007/s10549-005-9070-2 16261397
10. S Massarweh CK Osborne CJ Creighton, et al. 2008 Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function Cancer Res 68 3 826 833 1:CAS:528:DC%2BD1cXhtlygtrY%3D 10.1158/0008-5472.CAN-07-2707 18245484
11. D Jelovac G Sabnis BJ Long L Macedo OG Goloubeva AM Brodie 2005 Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole Cancer Res 65 12 5380 5389 1:CAS:528:DC%2BD2MXltFels74%3D 10.1158/0008-5472.CAN-04-4502 15958587
12. RJ Santen RX Song Z Zhang W Yue R Kumar 2004 Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer Clin Cancer Res 10 1 Pt 2 337S 345S 1:CAS:528:DC%2BD2cXkvF2ksA%3D%3D 10.1158/1078-0432.CCR-031207 14734489
13. S Masri S Phung X Wang, et al. 2008 Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor Cancer Res 68 12 4910 4918 1:CAS:528:DC%2BD1cXnt1ejtrc%3D 10.1158/0008-5472.CAN-08-0303 18559539
14. CM Chan LA Martin SR Johnston S Ali M Dowsett 2002 Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation J Steroid Biochem Mol Biol 81 4-5 333 341 1:CAS:528:DC%2BD38XnsVWrsLg%3D 10.1016/S0960-0760(02)00074-2 12361723
15. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2 281 297 1:CAS:528:DC%2BD2cXhtVals7o%3D 10.1016/S0092-8674(04)00045-5 14744438
16. C Llave Z Xie KD Kasschau JC Carrington 2002 Cleavage of scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA Science 297 5589 2053 2056 1:CAS:528:DC%2BD38Xnt1ansLo%3D 10.1126/science.1076311 12242443
17. JF Palatnik E Allen X Wu, et al. 2003 Control of leaf morphogenesis by microRNAs Nature 425 6955 257 263 1:CAS:528:DC%2BD3sXntlWns7w%3D 10.1038/nature01958 12931144
18. RC Lee RL Feinbaum V Ambros 1993 The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 5 843 854 1:CAS:528:DyaK2cXpslGqtA%3D%3D 10.1016/0092-8674(93)90529-Y 8252621
19. B Wightman I Ha G Ruvkun 1993 Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans Cell 75 5 855 862 1:CAS:528:DyaK2cXislyisA%3D%3D 10.1016/0092-8674(93) 90530-4 8252622
20. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 4 259 269 1:CAS:528:DC%2BD28XivVyqtrs%3D 10.1038/nrc1840 16557279
21. A Cimmino GA Calin M Fabbri, et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci USA 102 39 13944 13949 1:CAS:528:DC%2BD2MXhtVOqsbjK 10.1073/pnas.0506654102 16166262
22. SM Johnson H Grosshans J Shingara, et al. 2005 RAS is regulated by the let-7 microRNA family Cell 120 5 635 647 1:CAS:528:DC%2BD2MXis1yhsbs%3D 10.1016/j.cell.2005.01.014 15766527
23. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 7043 839 843 10.1038/nature03677 15944709
24. Q Huang K Gumireddy M Schrier, et al. 2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis Nat Cell Biol 10 2 202 210 1:CAS:528:DC%2BD1cXhs1Kiurk%3D 10.1038/ncb1681 18193036
25. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 7163 682 688 1:CAS:528:DC%2BD2sXhtFChurfF 10.1038/nature06174 17898713
26. JL Wrana L Attisano R Wieser F Ventura J Massague 1994 Mechanism of activation of the TGF-beta receptor Nature 370 6488 341 347 1:CAS:528: DyaK2cXlt1Kju78%3D 10.1038/370341a0 8047140
27. XH Feng R Derynck 2005 Specificity and versatility in tgf-beta signaling through Smads Annu Rev cell Dev Biol 21 659 693 1:CAS:528:DC%2BD2MXhtlektbjM 10.1146/annurev.cellbio.21.022404.142018 16212511
28. MB Buck C Knabbe 2006 TGF-beta signaling in breast cancer Ann NY Acad Sci 1089 119 126 1:CAS:528:DC%2BD2sXhsFertL0%3D 10.1196/annals.1386.024 17261761
29. PM Siegel W Shu RD Cardiff WJ Muller J Massague 2003 Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci USA 100 14 8430 8435 1:CAS:528:DC%2BD3sXlsFGntLc%3D 10.1073/pnas.0932636100 12808151
30. RS Muraoka Y Koh LR Roebuck, et al. 2003 Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1 Mol Cell Biol 23 23 8691 8703 1:CAS:528:DC%2BD3sXptFaisbk%3D 10.1128/MCB.23.23.8691-8703.2003 14612410
31. RF Tucker GD Shipley HL Moses RW Holley 1984 Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor Science 226 4675 705 707 1:CAS:528:DyaL2cXmt1emsbo%3D 10.1126/science.6093254 6093254
32. E Kalkhoven E Beraldi ML Panno JP De Winter JH Thijssen B Van Der Burg 1996 Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells Int J Cancer 65 5 682 687 1:CAS:528: DyaK28Xit12ktbk%3D 10.1002/(SICI)1097-0215(19960301)65:5<682::AID-IJC20>3. 0.CO;2-8 8598322
33. CL Arteaga KM Koli TC Dugger R Clarke 1999 Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta J Natl Cancer Inst 91 1 46 53 1:CAS:528:DyaK1MXlvFSgug%3D%3D 10.1093/jnci/91.1.46 9890169
34. YA Yoo YH Kim JS Kim JH Seo 2008 The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer Biochim Biophys Acta 1783 3 438 447 1:CAS:528:DC%2BD1cXitVGktr0%3D 10.1016/j.bbamcr. 2007.12.001 18164268
35. XZ Sun D Zhou S Chen 1997 Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells J Steroid Biochem Mol Biol 63 1-3 29 36 1:CAS:528:DyaK1cXksF2ltQ%3D%3D 10.1016/S0960-0760(97)00068-X 9449203
36. PE Lonning 2009 Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation? Eur J Cancer 45 4 527 535 1:STN:280:DC%2BD1M7ksVKhtQ%3D%3D 10.1016/j.ejca.2008.10.019 19062270
37. S Chen S Masri Y Hong, et al. 2007 New experimental models for aromatase inhibitor resistance J Steroid Biochem Mol Biol 106 1-5 8 15 1:CAS:528:DC%2BD2sXhtVWitbbK 10.1016/j.jsbmb.2007.05.020 17611102
38. TE Miller K Ghoshal B Ramaswamy, et al. 2008 MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 J Biol Chem 283 44 29897 29903 1:CAS:528:DC%2BD1cXht1ynt7nI 10.1074/jbc.M804612200 18708351
39. JJ Zhao J Lin H Yang, et al. 2008 MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer J Biol Chem 283 45 31079 31086 1:CAS:528:DC%2BD1cXhtlWjtLrE 10.1074/jbc.M806041200 18790736
40. JA Foekens AM Sieuwerts M Smid, et al. 2008 Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer Proc Natl Acad Sci USA 105 35 13021 13026 1:CAS:528:DC%2BD1cXhtFSmtrbN 10.1073/pnas.0803304105 18755890
41. C Blenkiron LD Goldstein NP Thorne, et al. 2007 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biol 8 10 R214 10.1186/gb-2007-8-10-r214 17922911
42. L Castellano G Giamas J Jacob, et al. 2009 The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response Proc Natl Acad Sci USA 106 37 15732 15737 1:CAS:528:DC%2BD1MXhtFyjsLnL 10.1073/pnas.0906947106 19706389
43. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA (New York, NY) 14(11):2290-2296
44. P Bhat-Nakshatri G Wang NR Collins, et al. 2009 Estradiol-regulated microRNAs control estradiol response in breast cancer cells Nucleic Acids Res 37 14 4850 4861 1:CAS:528:DC%2BD1MXhtVWitLvK 10.1093/nar/gkp500 19528081